Investor Presentation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Results presentation for the Q1 of FY26
Investor Presentation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Results Presentation for the quarter and financial year ended March 31, 2025.
Investor Presentation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Results presentation for the quarter and nine months ended December 31, 2024
Investor Presentation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Results Presentation for the quarter and half year ended 30th September, 2024
Investor Presentation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Results presentation for the quarter ended June 30, 2024
Investor Presentation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation Q4 and FY24 attached
Investor Presentation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Results Presentation for quarter and nine months ended December 31, 2023.
Investor Presentation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Results Presentation for the quarter and half year ended September 30, 2023
Investor Presentation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Results Presentation for the Quarter ended June 30, 2023
Investor Presentation Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find enclosed herewith the Results Presentation for the Quarter and Financial Year ended March 31, 2023 for your records.